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Abstract 
Recent molecular dynamics simulations (Herce and Garcia, PNAS, 104: 20805 
(2007)) have suggested that the arginine-rich HIV Tat peptides might be able to 
translocate by destabilizing and inducing transient pores in phospholipid bilayers. In this 
pathway for peptide translocation, arginine residues play a fundamental role not only in 
the binding of the peptide to the surface of the membrane but also in the destabilization 
and nucleation of transient pores across the bilayer, despite being charged and highly 
hydrophilic. Here we present a molecular dynamics simulation of a peptide composed of 
nine arginines (Arg-9) that shows that this peptide follows the same translocation 
pathway previously found for the Tat peptide. We test this hypothesis experimentally by 
measuring ionic currents across phospholipid bilayers and cell membranes through the 
pores induced by Arg-9 peptides. We find that Arg-9 peptides, in the presence of an 
electrostatic potential gradient, induce ionic currents across planar phospholipid bilayers, 
as well as in cultured osteosarcoma cells and human smooth muscle cells freshly isolated 
from the umbilical artery. Our results suggest that the mechanism of action of Arg-9 
peptide involves the creation of transient pores in lipid bilayers and cell membranes. 
 
Introduction 
 
Cell penetrating peptides (CPPs) are short sequences of amino acids (<30) 
capable of entering most mammalian cells. CPPs have the special property of carrying 
with them cargoes of a wide range of molecular size such as proteins, oligonucleotides, 
and even 200 nm liposomes (1-8). Many CPPs are highly cationic and hydrophilic, 
exhibiting no or relatively low amphipathicity when compared to other peptides that are 
known to interact with and permeabilize phospholipid membranes.  
The translocation mechanism by which these peptides are able to enter cells has 
remained elusive since their discovery (2, 3, 9, 10). There is ample evidence suggesting 
that the uptake is independent of metabolic energy and it does not involve any specific 
cell receptor (1, 3). Other reports indicate that the uptake may involve lipid raft mediated 
endocytotic pathways (11-13). Even when the uptake could initially follow an 
endocytotic pathway, arg-rich CPPs are still able to breach the vesicle membrane barrier 
to reach for example the cell nucleus (14). 
A common feature of cationic CPPs is that they form a rapid and tight interaction 
with extracellular glycosaminoglycans, such as heparan sulfate, heparin, and chondroitin 
sulfate B (14). However, whereas a significant part of the uptake of CPPs might involve 
heparan sulfate receptors, efficient internalization is observed even in their absence (15). 
Furthermore, these peptides are capable of entering giant unilamellar vesicles (GUVs) 
composed of model phospholipid membranes (16-19). These results suggest that these 
peptides can directly interact with the phospholipid bilayer altering its resting structure 
and that these changes facilitate peptide translocation. Taken together this evidence 
suggests that the binding of highly cationic CPPs to anionic plasma membrane 
components, such as phosphate and sulphate groups, could be an important step for 
effective peptide translocation across a phospholipid bilayer or the cell membrane.   
The relevance of peptide-phosphate interactions can be understood through a 
theoretical model that we recently proposed for the translocation of the Tat peptide (20). 
This model shows how these peptides may be able to nucleate a pore and passively 
diffuse across a phospholipid bilayer. This model shows the special importance of the 
arginine amino acids in the translocation mechanism. According to this model, the 
arginine and lysine amino acids initially bind to the phospholipid phosphate groups 
producing strong distortions to the bilayer relative to their resting structure. This is 
followed by the translocation of a single arginine amino acid towards the distal side 
attracted by phosphate groups and this event nucleates a water pore. The relevance of the 
Arg-phosphate interaction has been highlighted in several reports that indicate for 
example that polyarginine peptides translocate more efficiently than polylysine peptides 
and the Tat peptide (10, 21). The interaction of arginine amino acids with phosphate 
groups of the plasma membrane plays a fundamental role in other physiological process 
such as the voltage gating of potassium ion channels (22, 23). It has even been suggested 
that the use of arginine in voltage sensors might be an adaptation to the phospholipid 
composition of cell membranes (24).  
Several arginine rich antimicrobial peptides can also form pores in lipid bilayers 
and bacterial cell membranes (25, 26). It is known that antimicrobial peptides are able to 
translocate across the bacterial plasma membrane in an energy-independent manner. 
Since CPPs also seem capable of translocation in an energy independent manner, they 
could share a similar pore opening mechanism (1, 3, 20, 27). However, an important 
difference between hydrophilic CPPs and antimicrobial peptides is the lack of 
hydrophobic residues in the former case. It is known that the phospholipid bilayer of the 
cell membrane is not permeable to most ions and hydrophilic molecules. Therefore, it is 
generally assumed that a substantial hydrophobic content is necessary to directly interact 
with the core of the plasma membrane and nucleate a pore. Although CPPs are extremely 
hydrophilic, the model proposed for CPPs (20) suggests that arginine amino acids can 
efficiently disrupt and cross a phospholipid bilayer and nucleate a pore even in the 
absence of hydrophobic amino acids.  
It has been proven that polyarginine peptides composed of nine arginine amino 
acids (Arg-9) are able to translocate across cells very efficiently (28). This raises the 
question if molecular dynamics simulations would show a similar pathway for this highly 
hydrophilic and charged peptide as predicted for the Tat peptide. The simplicity of Arg-9 
over other CPPs also helps isolate the role of the Arg sidechain on the translocation 
without the effect of other sidechains. Therefore, in this work we study computationally 
the translocation of Arg-9 through a lipid bilayer and show that the translocation 
mechanism is the same as for the Tat peptide.  
Based on the theoretical translocation pathway found for Tat and Arg-9 the 
central hypothesis of the experimental work presented here is the following: If arginine-
rich CPPs disturb and induce pores in phospholipid membranes then ions should be able 
to flow across lipid membranes through these pores. Therefore, applying an electrostatic 
potential should produce ionic currents through the pores induced by CPPs across 
phospholipid bilayers and cell membranes. Consistent with this hypothesis, we detected 
ionic currents induced by Arg-9 on (a) model phospholipid membranes using the method 
of planar phospholipid bilayers  (29), and (b) on freshly isolated human umbilical artery 
(HUA) smooth muscle cells and on cultured osteosarcoma cells using the patch clamp 
technique (30). We found that the ionic permeability of phospholipid bilayers and cell 
membranes is increased by the presence of the Arg-9 peptides. We also explored other 
peptides and solution conditions that alter this permeability.  
This work covers systems with different degrees of complexity, ranging from 
simulations of very simple systems to experiments on live mammalian cells.   The 
molecular dynamics studies reported previously for the Tat peptides (20) and here for 
Arg-9 peptides were conducted on simple systems containing a single phospholipid 
composition (DOPC), a few peptides and water. Cell membranes and experimental model 
membranes are usually composed of multiple lipids (27, 31, 32), cell receptors and 
modified lipids. Here, we study experimentally a series of systems that are as simple as 
the systems modeled computationally (e.g., a DOPC planar phospholipid bilayer); 
systems that contain lipid mixtures (e.g., 3:1 DOPC: DOPG); and mammalian cells under 
different salt and pH conditions. This allow us to present physical, chemical and 
biological details of the interactions between Arg-rich peptides and the cell membrane 
that we believe are essential to unveil the cell translocation pathway for CPPs.  
 
Methods  
Molecular dynamics simulations 
Molecular dynamics simulations were performed to study the translocation 
mechanism of Arg-9 peptides across model membranes.  The Arg-9 peptides were placed 
in a periodically repeating box containing a pre-equilibrated lipid membrane composed of 
1,2-Dioleoyl-sn-Glycero-3-Phosphocholine (DOPC) lipids, and water molecules (33, 34). 
The peptides were placed near one side of the bilayer such that the Arg-9 peptides would 
bind mostly to one layer of the bilayer. These configurations are away from equilibrium. 
Here, we explored how the systems relax from these configurations. Due to periodic 
boundary conditions, there are two paths by which an Arg-9 peptide on one layer can 
move to bind the other layer: one which requires translocation, and another which 
requires diffusion of the Arg-9 peptide from the initial configuration near the water-
bilayer boundary on one layer to the other layer. Our calculations include a large number 
of water molecules such that binding to the proximal layer, given the initial conditions 
that we selected, is favored. The total length of the simulation was 500ns. 
The simulations were performed using the GROMACS package (35), on a cluster of dual 
Opteron processors. The simulated system consists of 4 Arg-9 peptides, 92 DOPC 
phospholipid molecules and 8795 water molecules. The overall temperature of the water, 
lipids, and peptides were kept constant, coupling independently each group of molecules 
at 323 K with a Berendsen thermostat (36). The pressure was coupled to a Berendsen 
barostat at 1 atm separately in every dimension (36). The temperature and pressure time 
constants of the coupling were 0.2 ps and 2 ps, respectively. An external electric field of 
0.05 V nm-1 was included pointing towards the distal side of the bilayer to qualitatively 
take into account the external electrostatic potential included in the experiments. The 
integration of the equations of motion was performed using a leap frog algorithm with a 
time step of 2 fs. Periodic boundary conditions were implemented in all systems. A cut-
off of 1 nm was implemented for the Lennard-Jones and the direct space part of the 
Ewald sum for Coulombic interactions. The Fourier space part of the Ewald splitting was 
computed using the particle-mesh Ewald method (37), with a grid length of 0.11 nm on 
the side and a cubic spline interpolation. Periodic boundary conditions and Ewald 
summations that do not include the surface term ensure system electro neutrality (38). We 
used the SPC/E (39), the lipid parameters were from Berger et al (33), and the peptide 
parameters were from the GROMACS force field (35). 
 
Planar lipid bilayers 
1,2-Dioleoyl-sn-Glycero-3-Phosphocholine (DOPC), and 1,2-Dioleoyl-sn-Glycero-3-
[Phospho-rac-(1-glycerol)] (DOPG), were purchased from Avanti Polar Lipids, Tat 
peptide, penetratin and Arg-9 were purchased from Global Peptides, Dap-9 was 
purchased form Chiscientific, Protegrin-1 (PG-1) was purchased from the core facility at 
Emory university, and n-hexadecane was purchased from Fisher Scientific. All reagents 
were used as received with no further purification. The lipid was dissolved in n-
hexadecane at a concentration of 200 mg/ml, and was used immediately. Compositions 
used were either 100% DOPC, or 3:1 DOPC:DOPG. Bilayers were formed over a 100 
micron diameter aperture in a polystyrene cup (Warner Instruments). The chambers and 
the cup were washed in sodium dodecyl sulfate (SDS) and distilled water before each 
experiment. The cup was then dried under a stream of nitrogen. Lipid solution was 
applied over the area surrounding the aperture using a thin glass rod. The lipid solution 
was then spread evenly over the surface using a stream of nitrogen.  The cup was inserted 
into a thermally conductive chamber (Warner Instruments) and the cup and chamber 
sides were both filled with 1 mL of 0.1M KCl solution, pH 7.4. Ag/AgCl electrodes were 
inserted in small electrode wells containing 3M KCl which were then connected to the 
cup and chamber liquid using salt bridges containing 3M KCl with 2.5% agar. The 
chamber was then placed in a BLM-TC thermocycler (Warner) and allowed to reach 
37°C. Before forming a bilayer, we checked that the current was greater than 1000 pA, 
indicating that there was no obstruction blocking the aperture. The lipid was then painted 
over the aperture again using a glass rod as an applicator. The formation of a bilayer was 
indicated by a sharp drop in current accompanied by an increase in bilayer capacitance. 
Current and capacitance were measured using a BC-535 patch clamp amplifier (Warner 
Instruments). Bilayers were required to reach a capacitance value greater than 40 pF to be 
used in our experiments. Once these conditions had been met and the capacitance and 
current had remained stable for at least 15 minutes, a transmembrane potential of 50 mV 
with respect to the cis side was applied across the bilayer, which was then allowed to 
again equilibrate until the capacitance and current were stable for 15 minutes, while 
making a baseline recording. Finally, the peptides were added to the cis-side to a final 
concentration of 7 µM. The data was then collected from the amperimeter through a 
Digidat 1440 data digitizer (Axon Instruments) at a sampling rate of 150 kHz and 
analyzed using the Clamplex 10.0 software (Molecular Devices Corp.). Signal filtering 
was achieved using the 4-pole bessel filter built into the amplifier unit, at a setting of 2 
kHz.           
 
 
Figure 1 Schematic representation of the planar lipid bilayer setup used to measure ionic 
currents across the bilayer induced by peptides added to the cis chamber. 
 
Cell isolation procedure 
Umbilical cords obtained after vaginal and cesarean delivery were placed in saline 
solution containing 130 mM NaCl, 4.7 mM KCl, 1.17 mM KH2PO4, 1.16 mM MgSO4, 
24 mM  NaHCO3, 2.5 mM CaCl2, pH 7.4 at 4°C and immediately transported to our 
laboratory and stored at 4°C. The arteries were dissected from the Wharton´s jelly just 
before the cell isolation procedure. Human umbilical artery (HUA) smooth muscle cells 
were obtained following a method described by Klockner (40) and later modified in our 
laboratory in order to diminish the enzyme content in the dissociation medium (DM) 
(41). Briefly, a segment of HUA was cleaned of any residual connective tissue, cut in 
small strips and placed for 15 min in a DM containing 130 mM NaCl, 1.2 mM KH2PO4, 5 
mM MgCl2, 5 mM HEPES, 6 mM glucose, pH was adjusted to 7.4 with NaOH. The 
strips were then placed in DM with 2 mg/ml collagenase type I during 25 min, with 
gentle agitation, at 35°C. After the incubation period the strips were washed with DM 
and single HUA smooth muscle cells were obtained by a gentle dispersion of the treated 
tissue using a Pasteur pipette. The remaining tissue and the supernatant containing 
isolated cells were stored at room temperature (~20°C) until used. 
 
Patch-clamp recordings 
HUA smooth muscle cells were allowed to settle onto the coverglass bottom of a 3 ml 
experimental chamber. The cells were observed with a mechanically stabilized, inverted 
microscope (Telaval 3, Carl Zeiss, Jena, Germany) equipped with a 40X objective lens. 
The chamber was perfused for 15 min, at 1 ml.min-1 by gravity, with the appropriate 
saline solution (see composition later) before the patch-clamp experiment was started. 
Application of test solutions was performed through a multibarreled pipette positioned 
close to the cell investigated. After each experiment on a single cell, the experimental 
chamber was replaced by another one containing a new sample of cells. Only well-
relaxed, spindle-shaped smooth muscle cells were used for electrophysiological 
recordings. Data were collected within 4-6 h after cell isolation. All experiments were 
performed at room temperature (~20°C). 
The standard tight-seal whole-cell configuration of the patch-clamp technique was 
used. Glass pipettes were drawn from WPI PG52165-4 glass on a two-stage vertical 
micropipette puller (PP-83, Narishige Scientific Instrument Laboratories, Tokyo, Japan) 
and pipette resistance ranged from 2 to 4 Mohms. Ionic currents were measured with an 
Axopatch 200A amplifier (Axon Instruments, Foster City, CA). Currents were filtered at 
2 kHz, digitized (Digidata 1200 Axon Instruments, Foster City, CA) at a sample 
frequency of 20 kHz. The experimental recordings were stored on a computer hard disk 
for later analysis.  
 
Solutions for whole cell experiments: The extracellular saline solution used for recording 
whole-cell ionic currents contained 130 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 6 mM 
glucose, and 5 mM HEPES. The pH was adjusted to 7.4 pH using KOP. 
The composition of the intracellular pipette solution contained 130 mM KCl, 5 mM 
Na2ATP, 1 mM MgCl2, 0.1 mM EGTA, and 5 mM HEPES. The pH was adjusted to 7.3 
with NaOH. 
Solutions for cell-attached experiments: The tip of the peptide was filled by capillarity 
with a solution composed of 140 mM KCl, 0.5 mM MgCl2, 10 mM HEPES, 10 mM 
Glucose, and 1 mM CaCl2. The pH 7.4 was adjusted using KOH. The rest of the pipette is 
filled with the same solution plus Arg-9 peptides at a concentration of 7 µM. The bath 
solution was composed of 140 mM KCl, 0.5 mM MgCl2, 10 mM HEPES, 10 mM 
Glucose, and 1 mM EGTA. The pH was adjusted to 7.4 using KOH.  
Solutions for inside-out experiments: Both bath and pipette solutions were the same 
composed of 140 mM KCl, 0.5 mM MgCl2, 10 mM HEPES, 10 mM Glucose, 1 mM 
EGTA. The pH 7.4 was adjusted using KOH. 
 
 
Figure 2 Schematic representations of the patch clamp configurations used to measure 
ionic currents across mammalian cell membranes induced by the Arg-9 peptides: (a) Cell 
attached (b) Whole-cell and (c) Inside out. 
 
Results and discussions 
 
Theoretical Model 
Recently, we proposed a mechanism for the translocation of the HIV-1 Tat 
peptide based on molecular dynamics simulations. This mechanism shows how these 
peptides are able to passively diffuse across phospholipid bilayers (20). The translocation 
mechanism of these peptides can be described as composed of four basic steps: (a) The 
peptides bind to the surface of the bilayer, attracted by the phosphate groups of the 
phospholipids. (b) As the surface concentration of peptides increases, the arrangement of 
lipids is strongly distorted compared to that in the resting membrane. (c) An arginine side 
chain translocates to the distal layer nucleating the formation of a water pore. (d) A few 
peptides translocate by diffusing on the surface of the pore and the pore closes. These 
simulations highlight the central role of the arginine amino acids, such as their strong 
attachment to the phosphate groups and their ability to induce strong distortions to the 
structure of the phospholipid bilayer. It has been reported that Arg-9 peptides internalize 
more efficiently than Tat peptides. Therefore, a natural question is if peptides composed 
entirely of arginine amino acids such as Arg-9 would follow a similar translocation 
pathway as the Tat peptide.   
We performed a molecular dynamics simulation of a system composed of 4 Arg-9 
peptides, 92 1,2-di-oleoyl-sn-glycero-3-phosphocholine (DOPC) phospholipid molecules 
and 8795 water molecules. The simulations were started from equilibrated lipid bilayer 
systems and extended for 500 ns. In Fig. 3 are shown four snapshots extracted from this 
MD simulation in which it can be seen that Arg-9 follows the same mechanism as was 
previously described for Tat.  
 
 
 
Figure 3 Four snapshots of a molecular dynamics simulation (a) A lateral view that 
shows how the peptides are bound to the membrane before translocation. (b) The 
translocation of an arginine amino acid surrounded by water molecules that nucleates the 
formation of a water pore. (c) Lateral view of the pore, translocated peptide surrounded 
by a dotted square line and a translocating peptide circled by an oval dotted line. (d) Top 
view of the pore. The simulated system consists of 4 Arg-9 peptides, 92 DOPC 
phospholipids and 8795 water molecules. The phospholipid molecules are represented 
with transparent white surfaces, the phosphate atoms are in yellow spheres, the peptide 
molecules are in red, any water molecule at a distance of less than 3.5 Å from any 
phospholipids or amino acid atom is colored in solid blue, and the rest of the water 
molecules appear as a transparent blue surface. 
 
During the first 50 ns the Arg-9 peptides bind to the phosphate groups in the 
proximal layer of the lipid bilayer. The guanidinum groups of the arginine side-chains 
make hydrogen bond contacts with various oxygen atoms of the lipid headgroups and the 
peptide is partially immersed into the bilayer, at the level of the glycerol groups. After 
100 ns an arginine side-chain is attracted to a phosphate group in the distal layer of the 
bilayer. This phosphate group and the Arg side chain carry some solvation water 
molecules with them, so they are never fully desolvated. During this period of time a 
water chain crossing the bilayer is formed and a toroidal pore is nucleated.  One of the 
Arg-9 peptides translocates by diffusing on the surface of the pore. In this calculation the 
toroidal pore remains open toward the end of 500 ns. We expect the complete 
translocation and closing of the pore to occur on the microsecond time scale. The radius 
of the toroidal pore varies in size having a maximum diameter of 2.5 nm. The pore 
surface is lined up with phosphate headgroups. The mechanism of arginine side chain 
insertion and pore formation is identical to the mechanism found for the Tat peptide (20). 
The destabilization of lipid membranes and the formation of pores induced by 
these peptides should lead to an increase in the ionic permeability of phospholipid 
bilayers and the cell membrane. To validate this prediction of the model, we investigated 
experimentally the Arg-9 permeabilizing effects in lipid membranes and mammalian cells 
using two electrophysiological setups as described below. 
 
Permeabilization of model lipid membranes 
If CPPs are able to destabilize phospholipid bilayers producing transient pores 
across them, then ionic permeabilization should be observed. To test this hypothesis on 
model lipid membranes we made phospholipid bilayers using the planar lipid bilayer 
(also known as the black lipid membrane) method (29). The basic idea of this setup (more 
details are described in the method section) is that the bilayer is made across a 100 µm 
diameter hole that separates two chambers filled with a saline solution. In each chamber 
an electrode is introduced to generate an electrostatic potential across the membrane and 
measure ionic currents. The chamber where the active electrode is introduced is 
conventionally called the cis chamber and the other chamber is called the trans chamber. 
The cis chamber is held at 50 mV relative to the trans chamber. The peptides are added to 
the cis chamber because according to the model it is expected that they would be more 
likely to cross the bilayer from the higher to the lower electrostatic potential, which 
corresponds to the potential difference between the exterior and interior of the cell. 
Addition of micromolar concentrations of Arg-9 to the aqueous solution bathing a 
planar bilayer membrane led to an increase of membrane conductance in all experiments 
(n > 50, where n is the number of experiments). Fig.4 (a) shows the permeabilization of a 
phospholipid bilayer composed of a lipid mixture of DOPC:DOPG (3:1) after the 
addition of Arg-9 at a concentration of 7µM to the cis chamber. As seen in Fig. 4 (a) after 
the peptide is added to the cis chamber the ionic permeabilization across the membrane 
increases. A similar effect is shown in Fig. 4 (c) for bilayers entirely composed of DOPC 
phospholipid molecules. This proves that anionic phospholipids such as DOPG are not 
strictly required for peptide permeabilization of the bilayer since the peptides are still 
able to interact and permeabilize purely zwitterionic DOPC phospholipid bilayers. The 
permeabilization increases both continuously and with discrete jumps. The recordings 
show that the permeability increases and reduces several times until finally the membrane 
breaks permanently. The transient current spikes were quite abrupt and most of the time 
did not resemble recordings of well-defined ionic channels such as voltage-dependent ion 
channels.  
 
Positive ions such as divalent Ca2+ ions would be expected to displace the 
arginine amino acids or screen the underlying membrane phosphate groups. The 
permeability of the plasma membrane produced by the peptides should therefore be 
reduced upon the addition of calcium chloride.  Indeed, as shown in Fig. 4 (b), when 
calcium chloride was added to the solution, the permeabilization of the membrane 
reduced to a low baseline level.  Moreover, as shown in Fig. 4 (d), when the peptides 
were added after adding 100 mM of CaCl2 to the solution, there was no increase in the 
permeability of the bilayer, consistent with the ability of the Ca2+ ions to mask the 
phosphate groups from the peptides. This finding highlights the importance of 
electrostatic interactions in the initiation of pore formation. 
 
The MD simulations suggest that reducing the length of the amino acid side chain 
and replacing the guanidinium group with an amine group would diminish the efficiency 
of peptide translocation. Therefore, we tested the effect of Dap-9 (composed of nine 2,3-
diaminopropanoic acid residues, Fig. 5), which has the same charge as Arg-9 but much 
shorter side chains and amine groups instead of guanidinium groups. As seen in Fig. 4 (e) 
Dap-9 does not permeabilize the phospholipid membrane. 
 
We also performed a negative control shown in Fig. 4 (f), using the same solution 
but with no peptide addition and no current increase was observed. 
 
Fig. 6 (a) shows the current induced by Arg-9 across the bilayer for a system with 
the same composition and held at the same voltage as in Fig. 4 (a). Fig. 6 (b) and (c) 
show the dependence of the current on the voltage. Each interval characterizes a common 
state observed during the permeabilization of the membrane: control I-V represents a 
control measurement before the peptide is added; I-V (i) is a measurement after the 
addition of the peptide but before the steady increase of the conductance across the 
bilayer; and I-V (ii) is a measurement during the steady increase of conductance across 
the lipid bilayer. As seen in the figure, current fluctuations were seen initially after the 
peptides were added, but the baseline current remained unchanged and there was no 
significant difference in the average current versus voltage recorded (Fig. 6 (b) I-V (i)), 
compared to the same measurement before adding the peptides (Fig. 6 (b) I-V control). 
However, after a few minutes the permeabilization became permanent (the current base 
line increased) and there was a marked increase in slope of the current versus voltage for 
I-V (ii) relative to that for control I-V. In Fig. 6 (a) and (c) it can be seen that after adding 
100mM of CaCl2 the permeability decreased. Furthermore, after waiting for more than 
100 min the permeability dropped to a very low baseline values as can be seen in Fig. 6 
(c) I-V (iv).  
These results could be interpreted in the following way: After the peptides are 
added to the solution they start binding the bilayer creating isolated local transient pores 
across the bilayer. Consequently, the current base line initially remains at the same level 
as that before adding Arg-9. The slope of the current vs. voltage plot in I-V (i) remains 
almost unchanged compared to that for the I-V control, indicating that the permeability 
increases transiently while the baseline remains most of the time unchanged. After a few 
minutes the surface density of membrane-bound peptides increases, destabilizing the 
membrane more strongly and more permanently as is reflected by the increase in the base 
line current at I-V (ii) and by the increase in the slope of the current versus voltage. After 
the addition of CaCl2 the permeability decreases indicating that Ca2+ ions might be 
competing for phosphate groups and displacing the Arg-9 peptides from the surface of 
the membrane. This results in the resealing of the phospholipid bilayer. 
 
 In the inset pictures of Fig. 6 and in Fig. 7 are shown amplified current traces. 
One can see discrete current jumps that resemble the behavior of ion channels in cells and 
rapidly fluctuating current jumps that can be clearly distinguished from most ionic 
channels. These latter types of signals can be used as a foot print to recognize the peptide 
interaction with the cell membrane besides the expected steady permeabilization 
increment with time. 
  
Our measurements show that most of the time the current fluctuates rapidly, while 
in some cases more stable current jumps that resemble ion channels can be observed. If 
we assume that these jumps are associated with the formation of stable pores across the 
membrane, we can estimate the average radius of these pores by measuring the 
conductance. To characterize this behavior we show in Fig. 2 of the supplementary 
material a histogram of the amplitude of those current jumps over 118 events. Assuming 
that the pore conductivity is equal to that of 100mM of KCl, we can calculate the pore 
radius for a conductance G of 4.6 pA/50 mV=0.92 10-10 S using σ=Gh/A. Where σ is the 
conductivity (~1.6 S m-1); A is the area of the pore; G is the conductance (~0.92 10-10 S); 
and h is the membrane thickness (~6 nm). The estimated pore diameter for this current 
value is d~ 2 √(Gh/σπ)=0.66 nm, which compares well with the pore diameter observed 
in the simulations. 
 
 
 
Figure 4 Permeabilization of phospholipid bilayers composed of a lipid mixture of DOPC:DOPG 
(3:1) (a) and (b) after the addition of 7µM of Arg-9 to the cis chamber, (c) phospholipid bilayer 
composed entirely of DOPC, (d) lipid mixture of DOPC:DOPG, the CaCl2 ions are added to the 
solution before the addition of the peptide, (e) control measurement on a lipid mixture of 
DOPC:DOPG adding the Dap-9 peptide, (f) control on a lipid mixture of DOPC:DOPG 
measurement without peptides. The arrow’s origin indicates the time at which the peptides or the 
CaCl2 are added to the solution. The potential of the cis chamber relative to the trans chamber 
(the holding potential) is 50mV. The ionic concentration is 100mM of KCl and the pH is 7.4.  
 
 
Figure 5 Side chain structures of the α-amino acids Dap, Lys, and Arg. 
 
 
 
 
Figure 6 Current across a planar lipid bilayer under the same conditions as in Fig. 4 (c, d). (a) An 
average over ten measurements of current as a function of voltage were carried out at six different 
time points: (I-V control) before adding the peptides, (I-V i) 10 minutes after adding the peptide, 
(I-V ii) 40 minutes after adding the peptide, (I-V iii) 30 minutes after adding CaCl2, and (I-V iv) 
70 minutes after adding CaCl2. The inset pictures show amplified sections of the current trace, the 
scaled time fraction if enclosed by a dotted square, when time and current are both scaled the 
scale is included in the inset picture. (b) and (c) Average current as a function of voltage. The 
voltage is incremented by 10mV between -90mV to 90mv and the potential is held for 150ms at 
each voltage. The points in (b) and in (c) are the average over 10 consecutive measurements taken 
at each of the intervals indicated in (a). It can be seen that after the peptide is added there are 
currents jumps before (I-V i) but there is not much difference in average between I-V control and 
(I-V i). However, after the permeabilization becomes permanent and the base line current starts to 
increase there is a marked increase in the slope of the current versus voltage (I-V ii) relative to the 
control I-V (I-V control). After addition of CaCl2 the ionic permeabilization reduces. In the last I-
V record (I-V iv), the current is even lower than the control current. This indicates that CaCl2 
reduces the permeability of the membrane to essentially zero.   
 
 
 
Figure 7 Fractions of current traces after the addition of 7µM of Arg-9 to the cis chamber as the 
time progress. The planar lipid bilayer is composed of a lipid mixture of DOPC:DOPG (3:1). It 
can be seen that as the time increases the permeabilization has a noisier trend. 
 
 
The change in permeability induced by polyarginine peptides is indicative of the 
relevance of arginine amino acids in the local destabilization of the bilayer and pore 
formation capabilities of CPPs. Although Arg-9 is the focus of this experimental work, 
we are currently investigating the effects of Tat, penetratin, and PG-1. The first is also a 
highly hydrophilic CPP, the second is a slightly more amphiphilic CPP, and the third is a 
pore forming arginine-rich amphiphilic antimicrobial peptide. We also observed in all 
these cases an increase in the permeabilization of the phospholipid bilayers upon addition 
to a final concentration of 7 µM (Fig. 1 of the supplementary material). These 
experiments are still underway. 
 
Permeability across mammalian cells 
Our computer simulations allowed us to develop a hypothetical model and unveil 
some microscopic details. However the simulated time that can be achieved and the size 
of the systems is small compared to the experiments on actual phospholipid bilayers. The 
increase in precision obtained with actual systems, although critical to verify any 
hypothesis, usually comes at the cost of losing atomistic details. In this way each system 
represents a different level of detail that complements the others. We have shown that the 
translocation mechanism is consistent with the permeability changes measured on lipid 
bilayers. Investigating the effect of these peptides on the cell is the final level of 
complexity that we chose to explore. The planar phospholipid bilayers systems do not 
contain the complexity and machinery present in cells. However, we can still establish a 
cause and effect correlation between the addition of CPPs to a cell, under various 
configurations, and the permeability behavior of the cells. 
The results obtained in lipid bilayers, where it is possible to see that current is 
able to flow across the membrane in the presence of the peptide, encouraged us to test the 
peptide effects on cell membranes of human smooth muscle cells and osteosarcoma cells, 
although these systems are structurally and functionally much more complex.  
To accomplish this task we used the patch-clamp technique, in different configurations 
(whole-cell, cell-attached and inside-out, each of them described in the methods section) 
in order to measure ionic currents induced by the peptide on the cell membrane. 
 
Whole cell: (global permeabilization of the cell) 
We studied the effects of Arg-9 on isolated human umbilical artery (HUA) 
smooth muscle cells in the whole-cell configuration (see methods for details). In this case 
the patch pipette containing a saline solution of a composition similar to the intracellular 
medium was tightly sealed to the membrane; after a soft suction the membrane patch 
under the pipette tip was ruptured and the solution comes in contact with the intracellular 
medium. An electrode placed inside the pipette measured the current across the whole 
plasma membrane of the cell and, at the same time, was able to control the voltage across 
the membrane. In this case the cells were clamped at a holding potential of -50 mV, 
hence evoking a macroscopic holding current, which we measured before and after 
adding Arg-9 to a final concentration of 0.07 or 7 µM to the bath solution. Fig. 8 (a) 
shows a typical time course of the current at -50 mV where we see that the peptide slowly 
increased the magnitude of this inward current. The effects of both concentrations of Arg-
9 were variable among the cells tested, and some of them did not show any significant 
changes (5 out of 7 cells tested for 0.07 µM; and 2 out of 9 cells tested for 7 µM). In the 
cells where the peptide produced an effect, the average holding current showed a 
significant increase over the control current measured in the absence of the peptide. The 
mean current increase induced by 7 µM concentration of Arg-9, expressed as per cent of 
the control current, is 126 ± 45 % (n=7). We also observed that Arg-9 induced 
instantaneous current jumps like the ones shown in Fig. 8 (b). A similar behavior could 
also be observed at other membrane potentials (data not shown).  
It is known that acidification of the extracellular medium could destabilize 
phospholipid bilayers, thereby enhancing the destabilizing effects induced by the peptide 
on the plasma membrane. Therefore, we tested the peptide effect on the holding current at 
-50 mV in an acid bath solution (pH = 5.5). Under this condition we tested 9 HUA 
smooth muscle cells, and in 6 of them the current increased to a much greater extent than 
at the physiological pH of 7.4. The mean current increase (Fig. 8 (c) and (d)) was in this 
case 460 ± 130 % (averaged over 6 experiments). 
 
 
 
Figure 8 (a) Time course of the increase of the inward membrane current after the addition of 7 
µM of Arg-9 to the extracellular solution in the whole-cell configuration in the case of HUA 
smooth muscle cells. (a) Three typical recordings of this current (pH 7.4), corresponding to the 
points (i), (ii) and (iii) indicated in (a) and (c). If the pH of the bath solution is lowered to 5.5, the 
increase in the inward current is more prominent. (d) Three typical recordings of this current, 
corresponding to the points (i), (ii) and (iii) indicated in (c). 
 
Cell attached and inside out: Local cell permeabilization 
We next tested the effect of Arg-9 on cells in the cell-attached and inside-out 
configurations. These configurations allowed us to measure the currents induced by the 
peptide in membrane areas which are small compared to the whole surface of the cell. 
In the cell-attached configuration the tip of the pipette was sealed to the cell 
membrane without rupturing it. Therefore, the pipette-solution was in contact with the 
extracellular face of the cell-membrane patch, and was maintained in this condition 
during the recording, while the intracellular cell content remained intact. The tip of the 
pipette was filled with a pipette solution without peptide, while the rest was back-filled 
with the same solution containing the peptide. This produces a time delay (a few minutes) 
before the peptide slowly diffuses into the tip and comes into contact with the membrane. 
The membrane potential of the cell was kept near 0 mV by bathing them with a high K+ 
extracellular solution, but the presence of the seal allowed the application of a 
transmembrane voltage of 50 mV (relative to the interior of the cell) across the patch 
under the pipette, which was maintained constant during all the recoding time. In Fig. 9 
we can observe several recordings of the current evoked by a concentration of 7 µM of 
Arg-9 in the pipette at different times after the seal was obtained in HUA smooth muscle 
cells. A concentration of 0.07 µM of the peptide was also tested (data not shown). 
 
 
 
Figure 9 Typical cell-attached recordings of the current evoked by the peptide placed inside the 
pipette in HUA smooth muscle cells at different times after obtaining the seal. 
 
In the majority of tested HUA smooth muscle cells, after periods of time ranging 
from 10 to 35 minutes, we began to observe rapidly fluctuating current jumps that 
resemble the ones we previously observed in artificial phospholipid bilayers. These 
signals do not follow a repetitive pattern and are difficult to characterize by the typical 
parameters used to study ionic channels, such as mean current amplitude, open 
probability or dwell times. Instead, they resemble the current patterns observed on 
perturbed membranes of different kind of cells exposed to mechanical stress (42, 43) or 
in cardiac cells stimulated by photosensitizer-generated reactive oxygen species (44). 
This characteristic signal can be observed in 6 out of 7 cells obtained from different 
samples of umbilical cords, although the effect of the peptide is variable in its magnitude. 
We can also observe similar rapidly fluctuating current jumps in some of our control cells 
(without peptide in the pipette), however, with a much lower frequency of appearance 
than in the presence of Arg-9. Cell-attached experiments with the peptide (0.07 µM) were 
also made in UMR106 osteosarcoma cells with similar results. 
Figure 10 shows current snapshots that compare the evolution of current with time 
for osteosarcoma, HUA smooth muscle cells, and phospholipid bilayers. It can be seen 
that in every case the ionic currents observed demonstrate a time-increasing rapidly 
fluctuating behavior. In the case of the phospholipid bilayer, a stepwise current can also 
be seen, which resembles the opening behavior of ionic channels. However, if the 
peptides produce discrete jumps in the cells these would not be easily distinguished from 
those belonging to the ion channels already present in the cells. Hence, in order to 
minimize the activation of voltage-operated channels, we tested the effects of the peptide 
using a -50 mV membrane potential, at which in these kind of cells most of these voltage-
operated ionic channels present a low open probability. Testing the peptide on a 
biological system, such as a cell, introduces some of the variables present in complex 
systems, such as the presence of different kinds of ionic channels and lipid composition, 
that are not present in the planar lipid bilayer experiments. 
 
 
 
 
Figure 10 Snapshots of typical recordings of the current evoked by the peptide (placed inside the 
pipette) at different times after obtaining the seal in the cell-attached configuration in a (a) 
osteosarcoma cell, (b) HUA smooth muscle cell, and a (c) phospholipid bilayer. It can be seen 
that as time increases the membrane is being increasingly permeabilized and the signal reflects a 
rapidly fluctuating current in every case.  
 
In the inside out configuration a micrometer portion of the cell surface was covered by 
the tip of the glass pipette, then was pulled out and only a small piece of the membrane 
remained in contact with the pipette. In this case the internal surface of the cell membrane 
was exposed to the bath solution. EGTA (1 mM), a calcium chelator was present to 
inhibit the activity of calcium dependent ionic channels. As in the case of the cell-
attached configuration, the recordings were obtained in a symmetric high-potassium 
saline solution. When a transmembrane potential of -50 mV (outside positive) was 
applied, a stable holding current appeared. Immediately after the addition of Arg-9 to a 
concentration of 7 μM to the bath solution (now in contact with the intracellular side of 
the membrane), the negative net current measured at -50 mV significantly changed 
reaching more positive current values (Δcurrent = 75±18 pA n=13). After that, we 
observed again the occurrence of rapidly fluctuating, unstable, variable current jumps, 
such as those observed in the last part of the recording shown in Fig 11. These two kinds 
of behaviors were seen only in the presence of Arg-9, and were similar in all 13 cells 
tested. They were not observed in control inside-out patches. The peptide effect seems to 
have two phases in this patch clamp configuration: an immediate improvement of seal 
resistance followed by an increase of the patch noise, reflecting the destabilizing effect 
observed in the other configurations. This could be partially explained by the 
observations made by Chico et al. (45) who reported that significant amounts of poly-D-
Arg are retained by plastic and glass surfaces. This finding could explain our results, 
because Arg-9 would be able to improve the seal by increasing the interaction between 
the cell membrane and the glass pipette, which is the base of the establishment of a high 
resistance seal. This effect does not exclude the fact that Arg-9 could then penetrate, by 
destabilization, the cell-membrane, as could be inferred by the occurrence of the typical 
noisy current but the real concentration of the effective peptide action could be much less 
than the 7 µM peptide tested concentration. 
 
 
 
 
Figure 11 Typical recording of Arg-9 effects in an inside-out patch obtained from a HUA smooth 
muscle cell in symmetrical ionic conditions. (a) recording showing the current measured at 
50 mV (outside negative) and its decrease induced by the Arg-9 addition at a 
concentration of 7 μM. After a few minutes, the current trace becomes rapidly fluctuating 
in presence of the peptide. The variability of these current jumps amplitude can be 
observed in the three traces of panel (b) extracted at different time intervals. 
 
Conclusions 
In this work, we show experimentally that Arg-9 peptides destabilize and 
permeabilize planar phospholipid bilayers and cell membranes consistent with our 
theoretical model. 
The proposed translocation mechanism for arginine rich cell-penetrating peptides 
involves the destabilization and the formation of transient pores in model lipid bilayers. 
This theoretical mechanism highlights the central role of the arginine amino acids for the 
peptide binding to the phospholipids and the nucleation of transient pores across 
phospholipid bilayers. However, it is usually assumed that to interact and permeabilize 
phospholipid membranes the peptides must have a high degree of hydrophobicity such as 
is the case of arginine-rich antimicrobial peptides. Nevertheless, we show that CPPs 
composed entirely of arginine amino acids, despite being charged and highly hydrophilic, 
are capable of interacting, destabilizing and permeabilizing phospholipid bilayers and 
mammalian cell membranes.  
We performed a molecular dynamics simulation of Arg-9 that reproduces the 
main steps for translocation previously observed for the Tat peptide (20). The peptides 
bind to the surface of the bilayer, attracted by the phosphate groups of the phospholipids. 
These interactions produce large local distortions to the phospholipid bilayer compared to 
its resting structure. These distortions reduce the hydrophobic free energy barrier of the 
bilayer and an arginine side chain translocates attracted by phosphate groups on the distal 
side. This helps the nucleation and the formation of a toroidal pore. Once the pore is 
formed, the peptides translocate by diffusing on the surface of the pore. The simulations 
highlight the central role of the arginine residues. This is in accordance with experimental 
evidence presented by Mitchell et al. (46), who showed that six or more guanidinium 
groups are required to efficiently penetrate the cell membranes of different kinds of cells. 
Moreover, they reported that Arg-9 peptides internalize more efficiently than Tat 
peptides, probably due to the higher content of arginine amino acids. Despite intense 
research, details of the cell penetration mechanism of poly-arginine peptides are still 
under discussion. Futaki and coworkers have recently reviewed the subject (47) and 
concluded that proteoglycans may play a crucial role as primary receptors for peptide 
internalization, and that both endocytosis and direct membrane translocation are possible 
entry routs for arginine rich peptides.  
Still, some of the most important points that seem to divide opinions are whether the 
process is dependent on cell metabolic energy, and whether it requires vesicle formation 
(i.e.,  endocytosis (48) and macropinocytosis (49), among others). There is experimental 
evidence showing the inhibition of poly-arginine uptake obtained by blocking the cell 
metabolism with sodium azide (46), by lowering the temperature to 4 ºC (50), and by 
macropinocytosis and endocytosis inhibitors (12, 49, 51). However, there are other 
reports that suggest that cell penetration is independent of metabolic cell energy. 
Confocal microscopy experiments showed that a significant amount of diffuse peptide 
internalization could also be observed, probably due to direct peptide translocation. 
Furthermore, it has been recently shown, with genetically engineered cells, that knocking 
down clathrin-mediated and caveolin-mediated endocytosis (52) does not affect the 
ability of Tat to enter cells. In this case, there is an open discussion on a broad spectrum 
of possible mechanisms (4, 50, 53). The results presented here can explain the 
observations of direct translocation of the peptides through a mechanism that is 
independent of metabolic cell energy.  
Our theoretical observations show that Arg-9 is able to nucleate transient pores 
that would allow ions to flow across it. Therefore, applying an electrostatic potential 
across the bilayer should induce a net ionic current that could be detected experimentally. 
We confirmed this prediction by measuring currents across planar phospholipd bilayers 
and both cultured and freshly isolated mammalian cells. The currents induced by Arg-9 
across planar phospholipid bilayers are most of the time rapidly fluctuating and in some 
cases they present discrete jumps that resemble the typical behavior of ion channels. The 
observed pattern of ionic currents induced by Arg-9 is quite similar in the three tested 
systems indicating that electrophysiological methods are useful to study the effect of 
these peptides on membranes. Future studies will be directed to the electrophysiological 
characterization of this mechanism. Patch clamp and planar lipid bilayers have been 
useful to characterize several peptides that permeabilize cell membranes such as, 
puroindolines (54), alamethicin (55, 56) and cobra cardiotoxin (57), among others.  
The electrostatic attraction between the arginine amino acids and the phosphate 
groups of the membrane is a pivotal step of the translocation model. Therefore, different 
ions and counter ions can have a strong effect on the translocation of these peptides if 
they are able to screen these interactions. If the CaCl2 concentration is increased (100 
mM) after adding the peptides, the permeabilization initiated by Arg-9 is strongly 
reduced. Moreover, no permeabilization of the phospholipid bilayer is observed if Arg-9 
is added to a solution with a high CaCl2 concentration. We speculate that calcium ions 
may be competing for the phosphate groups reducing in this way the binding of the 
peptides to the surface of the membrane. 
 The length of the arginine side chain facilitates the insertion of the amino acid 
chains. For shorter amino acid side chains, like 2,3-diaminopropanoic acid (Dap), the 
translocation of one side chain towards phosphates on the distal layer would require 
either a much thinner membrane or the translocation of more side chains at the same 
time, making this statistically much less favorable. Previous experimental reports show 
that by increasing the length of the side chain, the translocation of peptides increases 
significantly (28). Furthermore, if the guanidinium group is replaced by an amine group 
the uptake is in this case reduced (46). Therefore, we measured the effect on the current 
produced by Dap-9 which has the same charge as Arg-9, but much shorter side chains 
and amine groups instead of the guanidinum groups. No permeabilization of the 
phospholipid bilayer was observed for this peptide.  
 
 The results obtained using the patch-clamp technique in the whole-cell 
configuration on human vascular smooth muscle cells confirm that Arg-9 is able to 
permeabilize the cell membrane. This effect is stronger under acidic conditions (pH=5.5). 
Moreover, the results obtained with two other patch clamp configurations (cell-attached 
and inside-out patches) suggest that Arg-9 perturbs the membrane patch, thus producing a 
variable and rapidly fluctuating current that resembles the interaction between the peptide 
and planar lipid membranes. Interestingly, although an artificial phospholipid bilayer is a 
very simplified model of the cell-membrane, the measured currents share some common 
patterns. These observed currents might be due to the disorganization of the phospholipid 
bilayer caused by the interactions between positive charges of the peptides and the 
negative phosphate groups of the phospholipids. In the cell, if we consider the complete 
structure of the cell membrane, the peptides could also have a strong affinity for other 
negative membrane components like glycolipids or protein bound entities. Several 
authors have pointed out the importance of these interactions for the efficacy of the 
peptide internalization (14, 58-60). Therefore, to unveil the complexity of the CPPs 
translocation mechanism it is crucial to put together data from different theoretical and 
experimental approaches to allow a clear identification of each phase of the mechanism 
or mechanisms of translocation. The patch-clamp technique seems to be a very good 
technical choice to study the effect of these peptides mostly at the step of its interaction 
with the plasma membrane.  
The patch-clamp experiments are performed under saline conditions near the 
physiological ones, in the presence of Ca2+ at a 2.5 mM concentration, where it is 
possible to see the effects of the peptides. However, the inhibitory effect of Ca2+ ions, 
observed on planar lipid bilayers, could modify the influence of the Arg-9 peptides. It 
would be interesting to characterize the effect of these ions on cells. 
 
The physiological relevance of poly-arginine peptides on cell membranes and its 
ability to penetrate this selective barrier is interesting. However, these molecules have 
important applications beyond their capabilities as carriers. The poly-arginine peptide 
could have itself therapeutic use. For example, Uemura et al. (61, 62) have reported 
recently that heptamers of arginine inhibit vascular smooth muscle proliferation and 
reduced myointimal hyperplasia, a vascular response to injury involved in different 
pathological conditions like restenosis and atherosclerosis. Their findings open new 
opportunities where poly-arginine peptides could be an important tool to improve the 
treatments of vascular disease. 
 
We have demonstrated using theoretical and experimental results that a peptide 
made up entirely of arginine residues, a highly hydrophilic and charged molecule, is able 
to interact and permeabilize biological membranes. Furthermore, we have shown that the 
length of the side chains, the guanidinium group and counterions present can have a 
profound effect on the ability of these peptides to cross the membrane. Understanding the 
mechanism by which cell penetrating peptides disrupt the plasma membrane, will 
contribute to the fundamental knowledge of internalization mechanisms of charged 
molecules through lipid membranes, and the design of more efficient cargo carrying 
molecules which could lead to better drug delivery candidates. 
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